Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Penelope D Ottewell

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
JBMR Plus|September 22, 2025
ATM inhibition increases the anti-tumor efficacy of radium-223 (Ra-223) against prostate cancer bone metastasis in preclinical modelsDiane V Lefley, Callum G Jones, Jiabao Zhou, et al.
Cancers|April 3, 2021
Osteoblast-Derived Paracrine and Juxtacrine Signals Protect Disseminated Breast Cancer Cells from StressRussell Hughes, Xinyue Chen, Natasha Cowley, et al.
Cancers|October 14, 2022
Novel Methods of Targeting IL-1 Signalling for the Treatment of Breast Cancer Bone MetastasisJiabao Zhou, Jennifer M Down, Christopher N George, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 19, 2015
Mitotic quiescence, but not unique "stemness," marks the phenotype of bone metastasis-initiating cells in prostate cancerNing Wang, Freyja Docherty, Hannah K Brown, et al.
Cancer Letters|February 22, 2019
Pharmacological inhibition of the IKKε/TBK-1 axis potentiates the anti-tumour and anti-metastatic effects of Docetaxel in mouse models of breast cancerRyan T Bishop, Silvia Marino, Daniëlle de Ridder, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 21, 2015
The frequency of osteolytic bone metastasis is determined by conditions of the soil, not the number of seeds; evidence from in vivo models of breast and prostate cancerNing Wang, Kimberley J Reeves, Hannah K Brown, et al.
Bone Reports|August 26, 2024
Losartan alters osteoblast differentiation and increases bone mass through inhibition of TGF<i>B</i> signalling in vitro and in an OIM mouse modelMai Morita, Fawaz Arshad, Lewis A Quayle, et al.
Cancer Letters|June 1, 2020
Combined administration of a small-molecule inhibitor of TRAF6 and Docetaxel reduces breast cancer skeletal metastasis and osteolysisRyan T Bishop, Silvia Marino, Giovana Carrasco, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 24, 2014
Prostate cancer cells preferentially home to osteoblast-rich areas in the early stages of bone metastasis: evidence from in vivo modelsNing Wang, Freyja E Docherty, Hannah K Brown, et al.
Endocrine-Related Cancer|January 14, 2014
Different molecular profiles are associated with breast cancer cell homing compared with colonisation of bone: evidence using a novel bone-seeking cell lineFaith Nutter, Ingunn Holen, Hannah K Brown, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
JBMR Plus|September 22, 2025
ATM inhibition increases the anti-tumor efficacy of radium-223 (Ra-223) against prostate cancer bone metastasis in preclinical modelsDiane V Lefley, Callum G Jones, Jiabao Zhou, et al.
Cancers|April 3, 2021
Osteoblast-Derived Paracrine and Juxtacrine Signals Protect Disseminated Breast Cancer Cells from StressRussell Hughes, Xinyue Chen, Natasha Cowley, et al.
Cancers|October 14, 2022
Novel Methods of Targeting IL-1 Signalling for the Treatment of Breast Cancer Bone MetastasisJiabao Zhou, Jennifer M Down, Christopher N George, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 19, 2015
Mitotic quiescence, but not unique "stemness," marks the phenotype of bone metastasis-initiating cells in prostate cancerNing Wang, Freyja Docherty, Hannah K Brown, et al.
Cancer Letters|February 22, 2019
Pharmacological inhibition of the IKKε/TBK-1 axis potentiates the anti-tumour and anti-metastatic effects of Docetaxel in mouse models of breast cancerRyan T Bishop, Silvia Marino, Daniëlle de Ridder, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 21, 2015
The frequency of osteolytic bone metastasis is determined by conditions of the soil, not the number of seeds; evidence from in vivo models of breast and prostate cancerNing Wang, Kimberley J Reeves, Hannah K Brown, et al.
Bone Reports|August 26, 2024
Losartan alters osteoblast differentiation and increases bone mass through inhibition of TGF<i>B</i> signalling in vitro and in an OIM mouse modelMai Morita, Fawaz Arshad, Lewis A Quayle, et al.
Cancer Letters|June 1, 2020
Combined administration of a small-molecule inhibitor of TRAF6 and Docetaxel reduces breast cancer skeletal metastasis and osteolysisRyan T Bishop, Silvia Marino, Giovana Carrasco, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 24, 2014
Prostate cancer cells preferentially home to osteoblast-rich areas in the early stages of bone metastasis: evidence from in vivo modelsNing Wang, Freyja E Docherty, Hannah K Brown, et al.
Endocrine-Related Cancer|January 14, 2014
Different molecular profiles are associated with breast cancer cell homing compared with colonisation of bone: evidence using a novel bone-seeking cell lineFaith Nutter, Ingunn Holen, Hannah K Brown, et al.
Pageof 5